INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,955,436 | +38.9% | 79,298 | +30.0% | 0.26% | +51.8% |
| Q4 2022 | $2,128,430 | -37.7% | 61,004 | 0.0% | 0.17% | -41.4% |
| Q3 2022 | $3,414,000 | +1.0% | 61,004 | -6.6% | 0.29% | +1.4% |
| Q2 2022 | $3,381,000 | -41.2% | 65,316 | -17.4% | 0.29% | -36.6% |
| Q1 2022 | $5,747,000 | -57.1% | 79,089 | -30.2% | 0.45% | -47.3% |
| Q4 2021 | $13,398,000 | -32.9% | 113,311 | -23.9% | 0.86% | -31.0% |
| Q3 2021 | $19,962,000 | -20.6% | 148,806 | -4.1% | 1.24% | -2.7% |
| Q2 2021 | $25,129,000 | +10.7% | 155,201 | -45.1% | 1.28% | -15.4% |
| Q1 2021 | $22,708,000 | – | 282,953 | – | 1.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |